Otsuka Holdings Co., Ltd. Otsuka Group News RSS http://www.otsuka.com Otsuka Holdings Co., Ltd. Otsuka Group News RSS Thu, 03 Sep 2026 09:00:00 +0900 Thu, 03 Sep 2026 09:00:00 +0900 60 Otsuka Holdings Publishes “Integrated Report 2026” http://www.otsuka.com/en/group_news/detail.php?id=1622 Otsuka Holdings Publishes “Integrated Report 2026” Thu, 03 Sep 2026 09:00:00 +0900 1622 Otsuka Holdings Enters into Virtual PPA with Special Purpose Company Established with Sojitz –Advancing Carbon Neutral Initiatives through Expansion of Self-Generated Renewable Energy– http://www.otsuka.com/en/group_news/detail.php?id=1621 Otsuka Holdings Enters into Virtual PPA with Special Purpose Company Established with Sojitz –Advancing Carbon Neutral Initiatives through Expansion of Self-Generated Renewable Energy– Fri, 28 Aug 2026 09:00:00 +0900 1621 SOYJOY Matcha & Yuzu Rich and Intense Matcha Flavor with the Vibrant Aroma of Yuzu https://www.otsuka.co.jp/en/company/newsreleases/2026/20260820_1.html Thu, 20 Aug 2026 09:00:00 +0900 1618 Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer（Link to Taiho Oncology website） https://www.taihooncology.com/us/news/zipalertinib-plus-chemotherapy-first-line-phase-3-rezilient3-trial-data-selected-for-presidential-symposium-presentation-at-the-iaslc-2026-world-conference-on-lung-cancer/ Thu, 20 Aug 2026 09:00:00 +0900 1619 Otsuka Pharmaceutical Factory obtains approval for the manufacture and sale of the vasopressin V₂-receptor antagonist “Tolvaptan OD tablets 30 mg Otsuka” https://www.otsukakj.jp/en/news_release/20260817.html Mon, 17 Aug 2026 09:00:00 +0900 1616 Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer https://www.taiho.co.jp/en/release/2026/20260813.html Thu, 13 Aug 2026 09:00:00 +0900 1617 Otsuka Sponsors the 20th Asian Games Aichi-Nagoya 2026 Supporting Conditioning and Performance with the Global Brand POCARI SWEAT https://www.otsuka.co.jp/en/company/newsreleases/2026/20260804_1.html Tue, 04 Aug 2026 09:00:00 +0900 1614 Otsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy https://www.otsuka.co.jp/en/company/newsreleases/2026/20260804_2.html Tue, 04 Aug 2026 09:00:00 +0900 1615 Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies Optimizing Manufacturing Processes to Enable Stable Production of High-Quality ADCs https://www.taiho.co.jp/en/release/2026/20260803.html Mon, 03 Aug 2026 09:00:00 +0900 1611 The Results Suggest the Potential Usefulness of S-Equol in Women with Severe Symptoms of PMS and PMDD New Findings Contribute to Advancing Support for Women’s Health https://www.otsuka.co.jp/en/company/newsreleases/2026/20260730_1.html Thu, 30 Jul 2026 09:00:00 +0900 1613